Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Akari Therapeutics PLC (AKTX) had Weighted-Average Shares Outstanding (Diluted) of 1.48B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-14.46M |
|
-- |
|
-- |
|
$15.76M |
|
$-15.76M |
|
$0.44M |
|
$-15.31M |
|
$-15.31M |
|
$-14.46M |
|
$-14.46M |
|
$-14.46M |
|
$-14.46M |
|
$-15.76M |
|
$-15.76M |
|
1.48B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.48B |
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$3.59M |
|
-- |
|
$30.30M |
|
$33.89M |
|
$13.41M |
|
-- |
|
$6.09M |
|
$19.51M |
|
$14.38M |
|
$-15.92M |
|
$14.38M |
|
1.14B |
|
| Cash Flow Statement Financials | |
$-2.49M |
|
-- |
|
$0.05M |
|
$5.26M |
|
$2.83M |
|
$-2.44M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.27 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-100.52% |
|
90.80% |
|
-42.65% |
|
-100.52% |
|
$0.01 |
|
$-0.00 |
|
$-0.00 |
|